This article is from the WebMD News Archive
FDA OKs New Antidepressant Pristiq
March 3, 2008 -- The FDA has approved Pristiq, a new antidepressant that's a modified version of the antidepressant Effexor XR, for the treatment of major depressive disorder in adults.
Pristiq and Effexor XR are made by Wyeth .
Pristiq, which is taken once daily and isn't approved for pediatric patients, will be available in the second quarter of 2008, Wyeth notes.
Pristiq belongs to a class of drugs called serotonin norepinephrine reuptake inhibitors (SNRIs). According to Wyeth, the FDA approved Pristiq based on four studies in which Pristiq trumped a placebo pill at treating major depressive disorder in adults.
Pristiq has also been studied as a treatment for menopausal hot flashes and night sweats. But so far, the drug has only been approved for depression treatment.
Today in Depression
WebMD Special Sections
Health Solutions From Our Sponsors
©2005-2012 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.